US BANCORP \DE\

Bank

Position in OCUL — Ocular Therapeutix, Inc

CIK 36104 MINNEAPOLIS, MN

Position in OCUL

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,389

+$426 QoQ

Shares Held

447

-4.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#235

of 257 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 45% Shared 0% None 55%

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. OCUL ranks #149 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	66,580	$16,296,786
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,020	$15,905,293
3	TECH	BIO-TECHNE Corp	137,966	$9,747,297
4	REGN	Regeneron Pharmaceuticals, Inc.	5,330	$3,323,466
5	ARGX	Argenx SE	3,495	$3,242,555
6	ARWR	Arrowhead Pharmaceuticals, Inc.	38,226	$3,115,799
7	JAZZ	Jazz Pharmaceuticals plc	10,103	$2,434,518
8	GMAB	Genmab A/S	88,420	$2,428,896

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,389	447	-4.5%	Shares	Defined	2026-08-12
2026-03-31	$3,963	468	+84.3%	Shares	Defined	2026-05-15
2025-12-31	$3,083	254	-33.5%	Shares	Defined	2026-01-30
2025-09-30	$4,465	382	-5.2%	Shares	Defined	2025-11-12
2025-06-30	$3,739	403	-34.5%	Shares	Defined	2025-07-24
2025-03-31	$4,507	615	+94.0%	Shares	Defined	2025-05-08
2024-12-31	$2,706	317	-64.6%	Shares	Defined	2025-02-05
2024-09-30	$7,786	895	-62.0%	Shares	Defined	2024-10-28
2024-06-30	$16,108	2,355	-21.8%	Shares	Defined	2024-08-07
2022-09-30	$12,495	3,011	+325.9%	Shares	Defined	2022-10-27
2021-12-31	$4,927	707	-99.1%	Shares	Defined	2022-02-11
2021-09-30	$825,000	82,500	-0.3%	Shares	Other	2021-11-10
2021-06-30	$1,173,735	82,774	-0.2%	Shares	Defined	2021-08-05
2021-03-31	$1,361,570	82,972	0.0%	Shares	Defined	2021-04-28
2020-12-31	$1,717,520	82,972	—	Shares	Defined	2021-02-04
No filing history on record for this holder in this stock.